James Mittra

发表

The Socio-Political Economy of Pharmaceutical Mergers: A Case Study of Sanofi and Aventis

James Mittra, James Mittra, 2006, Technol. Anal. Strateg. Manag..

Innovation Processes in Genomics Industry Sectors

James Mittra, 2003 .

The future of pharmaceutical innovation: new challenges and opportunities

David Wield, Joyce Tait, James Mittra, 2011 .

The “Entrepreneurial State” and the Leveraging of Life in the Field of Regenerative Medicine

John Gardner, Andrew Webster, James Mittra, 2017 .

STATE-OF-THE-ART IN THE SCIENCE AND TECHNOLOGY

James Mittra, Christopher-Paul Milne, 2013 .

Evolution of the Life Science Industries

Robin Williams, James Mittra, 2007, Technol. Anal. Strateg. Manag..

Repairing the 'Broken Middle' of the Health Innovation Pathway: Exploring Diverse Practitioner Perspectives on the Emergence and Role of 'Translational Medicine'

James Mittra, James Mittra, 2013 .

Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms

James Mittra, J. Mittra, 2007, Technol. Anal. Strateg. Manag..

Methodology for the Analysis of Life Science Innovation Systems (ALSIS) and its Application to Three Case Studies

James Mittra, Michele Mastroeni, Joyce Tait, 2012 .

Regenerative medicine as a disruptive technology: implications for manufacturing & clinical adoption

Elizabeth Tait, James Mittra, Geoffrey Banda, 2019, Cell and Gene Therapy Insights.

Understanding the emergence and evolution of new business models in the UK regenerative medicine sector

Andrew Watkins, Joyce Tait, James Mittra, 2019, Technol. Anal. Strateg. Manag..

Regulatory and market influences on innovation pathways for the development of new antimicrobial drugs

James Mittra, Ann Bruce, Joyce Tait, 2019, Technol. Anal. Strateg. Manag..

Political influences on biotechnology-based innovation for European agriculture: risk-assessment and risk management

James Mittra, Michele Mastroeni, Joyce Tait, 2019, Technol. Anal. Strateg. Manag..

From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.

David Wield, James Mittra, Joyce Tait, 2011, Trends in biotechnology.

Analysing stratified medicine business models and value systems: innovation-regulation interactions.

James Mittra, Joyce Tait, J. Tait, 2012, New biotechnology.